MTTP
Basic information
Region (hg38): 4:99564081-99623997
Previous symbols: [ "MTP" ]
Links
Phenotypes
GenCC
Source:
- abetalipoproteinemia (Strong), mode of inheritance: AR
- abetalipoproteinemia (Strong), mode of inheritance: AR
- abetalipoproteinemia (Supportive), mode of inheritance: AR
- abetalipoproteinemia (Definitive), mode of inheritance: AR
- abetalipoproteinemia (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Abetalipoproteinemia | AR | Gastrointestinal | Dietary measures (eg, with a low fat diet and supplementation of essential fatty acids and fat-soluble vitamins) can be beneficial, and early initiation can prevent/decrease severe sequelae | Gastrointestinal; Hematologic; Neurologic; Ophthalmologic | 15411425; 14925152; 13745738; 14237436; 4135110; 848999; 716878; 7425890; 6959555; 2339706; 1439810; 8361539; 9686820; 17275380; 18239027; 18611256; 20402070; 21333248; 21394827; 21502686; 23090820; 23556456; 24288038 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (63 variants)
- Abetalipoproteinaemia (14 variants)
- MTTP-related disorder (2 variants)
- Inborn genetic diseases (1 variants)
- Metabolic syndrome X;Abetalipoproteinaemia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MTTP gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 309 | 316 | ||||
missense | 255 | 22 | 281 | |||
nonsense | 22 | 29 | 52 | |||
start loss | 0 | |||||
frameshift | 39 | 29 | 68 | |||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 17 | 24 | ||||
splice region | 1 | 13 | 55 | 4 | 73 | |
non coding | 28 | 149 | 47 | 224 | ||
Total | 69 | 77 | 287 | 481 | 54 |
Highest pathogenic variant AF is 0.0000394
Variants in MTTP
This is a list of pathogenic ClinVar variants found in the MTTP region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
4-99564087-G-C | Abetalipoproteinaemia • not specified | Benign (Jun 14, 2016) | ||
4-99564098-G-A | Abetalipoproteinaemia | Benign (Jun 14, 2016) | ||
4-99564125-G-A | Abetalipoproteinaemia • not specified • MTTP-related disorder | Conflicting classifications of pathogenicity (Mar 01, 2023) | ||
4-99564134-G-A | Abetalipoproteinaemia | Uncertain significance (Jan 13, 2018) | ||
4-99564183-TC-T | Uncertain significance (Jun 02, 2021) | |||
4-99564186-C-G | Abetalipoproteinaemia | Uncertain significance (Jan 12, 2018) | ||
4-99564190-C-A | Abetalipoproteinaemia | Uncertain significance (Jan 13, 2018) | ||
4-99564240-G-A | MTTP-related disorder | Likely benign (Sep 13, 2019) | ||
4-99574331-G-T | Benign (Jan 22, 2024) | |||
4-99574660-T-C | Benign (Jan 22, 2024) | |||
4-99574826-T-C | Abetalipoproteinaemia | Uncertain significance (Jan 13, 2018) | ||
4-99574828-C-T | Abetalipoproteinaemia | Uncertain significance (Jan 13, 2018) | ||
4-99574856-C-T | Abetalipoproteinaemia | Uncertain significance (Jan 13, 2018) | ||
4-99574882-T-C | Abetalipoproteinaemia | Uncertain significance (Jan 13, 2018) | ||
4-99574882-TGGATGCAGTTGAGGATTGCTGGTCAATATGATTCTTCTTGCTGTGC-T | Uncertain significance (Dec 10, 2021) | |||
4-99574890-G-A | Abetalipoproteinaemia | Uncertain significance (Jan 12, 2018) | ||
4-99574904-G-A | Abetalipoproteinaemia | Likely benign (Jul 11, 2024) | ||
4-99574916-CT-C | Pathogenic (Jun 25, 2023) | |||
4-99574921-T-TG | Likely pathogenic (Aug 01, 2022) | |||
4-99574922-G-C | Inborn genetic diseases | Uncertain significance (Jun 02, 2024) | ||
4-99574925-G-T | Inborn genetic diseases | Uncertain significance (Jan 26, 2022) | ||
4-99574927-G-T | Likely benign (Feb 01, 2024) | |||
4-99574929-T-G | Uncertain significance (Jul 22, 2022) | |||
4-99574931-T-TCTGAA | Abetalipoproteinaemia | Likely pathogenic (Feb 28, 2022) | ||
4-99574933-T-C | Likely benign (Sep 24, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MTTP | protein_coding | protein_coding | ENST00000457717 | 18 | 60239 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000104 | 1.00 | 125680 | 0 | 68 | 125748 | 0.000270 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.03 | 402 | 464 | 0.866 | 0.0000251 | 5851 |
Missense in Polyphen | 69 | 104.36 | 0.66117 | 1353 | ||
Synonymous | 0.538 | 164 | 173 | 0.948 | 0.00000999 | 1733 |
Loss of Function | 3.66 | 16 | 41.4 | 0.386 | 0.00000204 | 546 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000305 | 0.000304 |
Ashkenazi Jewish | 0.00268 | 0.00268 |
East Asian | 0.000272 | 0.000272 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000220 | 0.000220 |
Middle Eastern | 0.000272 | 0.000272 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the transport of triglyceride, cholesteryl ester, and phospholipid between phospholipid surfaces (PubMed:23475612, PubMed:8939939, PubMed:26224785, PubMed:25108285, PubMed:22236406). Required for the secretion of plasma lipoproteins that contain apolipoprotein B (PubMed:23475612, PubMed:8939939, PubMed:26224785). {ECO:0000269|PubMed:22236406, ECO:0000269|PubMed:23475612, ECO:0000269|PubMed:25108285, ECO:0000269|PubMed:26224785, ECO:0000269|PubMed:8939939}.;
- Disease
- DISEASE: Abetalipoproteinemia (ABL) [MIM:200100]: An autosomal recessive disorder of lipoprotein metabolism. Affected individuals produce virtually no circulating apolipoprotein B-containing lipoproteins (chylomicrons, VLDL, LDL, lipoprotein(A)). Malabsorption of the antioxidant vitamin E occurs, leading to spinocerebellar and retinal degeneration. {ECO:0000269|PubMed:10679949, ECO:0000269|PubMed:10946006, ECO:0000269|PubMed:22236406, ECO:0000269|PubMed:23475612, ECO:0000269|PubMed:25108285, ECO:0000269|PubMed:26224785, ECO:0000269|PubMed:8939939}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Fat digestion and absorption - Homo sapiens (human);Statin Pathway, Pharmacodynamics;Demo complete;Statin Pathway;Chylomicron assembly;VLDL assembly;Plasma lipoprotein assembly;Transport of small molecules;Glycerophospholipid metabolism;Plasma lipoprotein assembly, remodeling, and clearance
(Consensus)
Recessive Scores
- pRec
- 0.450
Intolerance Scores
- loftool
- 0.582
- rvis_EVS
- 1.43
- rvis_percentile_EVS
- 94.99
Haploinsufficiency Scores
- pHI
- 0.364
- hipred
- Y
- hipred_score
- 0.589
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.691
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | Medium | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Mttp
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; embryo phenotype; liver/biliary system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Zebrafish Information Network
- Gene name
- mttp
- Affected structure
- subintestinal vein
- Phenotype tag
- abnormal
- Phenotype quality
- morphology
Gene ontology
- Biological process
- lipid metabolic process;protein secretion;phospholipid transport;triglyceride transport;plasma lipoprotein particle assembly;chylomicron assembly;very-low-density lipoprotein particle assembly;lipoprotein metabolic process;cholesterol homeostasis
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum lumen;Golgi apparatus;basolateral plasma membrane;receptor complex
- Molecular function
- lipid transporter activity;protein binding;phospholipid transporter activity;lipid binding;protein heterodimerization activity